Citation Impact
Citing Papers
Protein Kinase D3 (PKD3) Contributes to Prostate Cancer Cell Growth and Survival Through a PKCε/PKD3 Pathway Downstream of Akt and ERK 1/2
2008
miR-205 Exerts Tumor-Suppressive Functions in Human Prostate through Down-regulation of Protein Kinase Cε
2009
Epithelialization in Wound Healing: A Comprehensive Review
2014 Standout
Protein kinase Cε makes the life and death decision
2007
Glutamate Receptor Ion Channels: Structure, Regulation, and Function
2010 Standout
Apigenin Inhibition of Involucrin Gene Expression Is Associated with a Specific Reduction in Phosphorylation of Protein Kinase Cδ Tyr311
2006
Oxyl radicals, redox-sensitive signalling cascades and antioxidants
2007 Standout
UV irradiation increases ROS production via PKCδ signaling in primary murine fibroblasts
2008
Silver Nanoparticles Synthesized Using Carica papaya Leaf Extract (AgNPs-PLE) Causes Cell Cycle Arrest and Apoptosis in Human Prostate (DU145) Cancer Cells
2020 Standout
Potent inactivation of representative members of each PKC isozyme subfamily and PKD via S-thiolation by the tumor-promotion/progression antagonist glutathione but not by its precursor cysteine
2001
Chemotherapy-Induced Ca2+ Release Stimulates Breast Cancer Stem Cell Enrichment
2017 StandoutNobel
Smoldering and polarized inflammation in the initiation and promotion of malignant disease
2005 Standout
The human keratins: biology and pathology
2008 Standout
Lifestyle-related factors and environmental agents causing cancer: An overview
2007 StandoutNobel
Plumbagin induces ROS-mediated apoptosis in human promyelocytic leukemia cells in vivo
2009
Polyamines and cancer: implications for chemotherapy and chemoprevention
2013
Targeting Polyamines and Inflammation for Cancer Prevention
2010
Nuclear factor-κB in cancer development and progression
2006 StandoutNature
Natural products to drugs: natural product-derived compounds in clinical trials
2008 Standout
The JAK/STAT signaling pathway: from bench to clinic
2021 Standout
Constitutive activation and targeted disruption of signal transducer and activator of transcription 3 (Stat3) in mouse epidermis reveal its critical role in UVB-induced skin carcinogenesis
2009
Natural product-based nanoformulations for cancer therapy: Opportunities and challenges
2019 Standout
Targeting the IL-6/JAK/STAT3 signalling axis in cancer
2018 Standout
Targeting protein kinase C and “non-kinase” phorbol ester receptors: Emerging concepts and therapeutic implications
2005
NF-κB and STAT3 in glioblastoma: therapeutic targets coming of age
2014
Plumbagin from Plumbago Zeylanica L Induces Apoptosis in Human Non-small Cell Lung Cancer Cell Lines through NF-κB Inactivation
2013
STATs in cancer inflammation and immunity: a leading role for STAT3
2009 Standout
Tumour-educated macrophages promote tumour progression and metastasis
2004 Standout
The Emerging Hallmarks of Cancer Metabolism
2016 Standout
Cancer chemoprevention and chemotherapy: Dietary polyphenols and signalling pathways
2008 Standout
Oxidative stress mediates cell surface expression of SS-A/Ro antigen on keratinocytes
2002 StandoutNobel
Targeting polyamine metabolism and function in cancer and other hyperproliferative diseases
2007
Tumor metastasis: mechanistic insights and clinical challenges
2006 Standout
Protein kinase C and other diacylglycerol effectors in cancer
2007
Cisplatin in cancer therapy: Molecular mechanisms of action
2014 Standout
Signal transducer and activator of transcription 3 (Stat3) in epithelial carcinogenesis
2007
Chemopreventive properties of apple procyanidins on human colon cancer-derived metastatic SW620 cells and in a rat model of colon carcinogenesis
2005
Modeling metastasis in vivo
2004
Tumour necrosis factor-α mediates tumour promotion via a PKCα- and AP-1-dependent pathway
2002
Signal Transducer and Activator of Transcription‐3, Inflammation, and Cancer
2009 Standout
ROS signalling in the biology of cancer
2017 Standout
Curcumin: From ancient medicine to current clinical trials
2008 Standout
Matrix metalloproteinases and tumor metastasis
2006 Standout
NF-κB: linking inflammation and immunity to cancer development and progression
2005 Standout
Arctigenin enhances chemosensitivity of cancer cells to cisplatin through inhibition of the STAT3 signaling pathway
2011
Mechanisms of Insulin Action and Insulin Resistance
2018 Standout
Inhibition of the Signal Transducer and Activator of Transcription-3 (STAT3) Signaling Pathway by 4-Oxo-1-Phenyl-1,4-Dihydroquinoline-3-Carboxylic Acid Esters
2008
Apoptosis: A Target for Anticancer Therapy
2018 Standout
Oxidative Stress, Prooxidants, and Antioxidants: The Interplay
2014 Standout
5-Hydroxy-2-Methyl-1,4-Naphthoquinone, a Vitamin K3 Analogue, Suppresses STAT3 Activation Pathway through Induction of Protein Tyrosine Phosphatase, SHP-1: Potential Role in Chemosensitization
2010
Protein kinase C: poised to signal
2009
Solar and ultraviolet radiation
2004
Bright Side of Lignin Depolymerization: Toward New Platform Chemicals
2018 Standout
Ingenol Mebutate Field-Directed Treatment of UVB-Damaged Skin Reduces Lesion Formation and Removes Mutant p53 Patches
2011
Protein Kinase Cε, which Sensitizes Skin to Sun's UV Radiation–Induced Cutaneous Damage and Development of Squamous Cell Carcinomas, Associates with Stat3
2007
Spermidine in health and disease
2018 StandoutScience
Transgenic Overexpression of RasGRP1 in Mouse Epidermis Results in Spontaneous Tumors of the Skin
2007
A Historical Overview of Natural Products in Drug Discovery
2012 Standout
Characterization of the Interaction of Ingenol 3-Angelate with Protein Kinase C
2004
The Inflammasomes: Guardians of the Body
2009 Standout
Natural product and natural product derived drugs in clinical trials
2014 Standout
Polyamines Modulate AMPA Receptor–Dependent Synaptic Responses in Immature Layer V Pyramidal Neurons
2004
Advances in Copper Complexes as Anticancer Agents
2013 Standout
Plant Secondary Metabolites as Anticancer Agents: Successes in Clinical Trials and Therapeutic Application
2018 Standout
Euphorbia Diterpenes: Isolation, Structure, Biological Activity, and Synthesis (2008–2012)
2014 Standout
Cytotoxicity of the traditional chinese medicine (TCM) plumbagin in its copper chemistry
2009
Quinones Derived from Plant Secondary Metabolites as Anti-cancer Agents
2013
Hydrogen Sulfide Mediates Cardioprotection Through Nrf2 Signaling
2009 Standout
Perspectives on medicinal properties of plumbagin and its analogs
2010 Standout
Plumbagin induces ROS-mediated apoptosis and cell cycle arrest and inhibits EMT in human cervical carcinoma cells
2018
Works of Nancy E. Dreckschmidt being referenced
A Randomized, Double-Blind, Placebo-Controlled Phase 3 Skin Cancer Prevention Study of α-Difluoromethylornithine in Subjects with Previous History of Skin Cancer
2010
Protein kinase Cɛ mediates Stat3Ser727 phosphorylation, Stat3-regulated gene expression, and cell invasion in various human cancer cell lines through integration with MAPK cascade (RAF-1, MEK1/2, and ERK1/2)
2010
Polyamine analog bis(ethylamino)-5,10,15-triazanonadecane (BE-4-4-4-4) enhances simian virus 40 late gene expression
1999
Relation of the induction of epidermal ornithine decarboxylase and hyperplasia to the different skin tumor-promotion susceptibilities of protein kinase C?, -? and -? transgenic mice
2001
Protein kinase Cδ-mediated signal to ornithine decarboxylase induction is independent of skin tumor suppression
2002
Protein Kinase Cε Interacts with Signal Transducers and Activators of Transcription 3 (Stat3), Phosphorylates Stat3Ser727, and Regulates Its Constitutive Activation in Prostate Cancer
2007
Plumbagin, a Medicinal Plant–Derived Naphthoquinone, Is a Novel Inhibitor of the Growth and Invasion of Hormone-Refractory Prostate Cancer
2008
Protein Kinase C ε Is an Endogenous Photosensitizer That Enhances Ultraviolet Radiation-Induced Cutaneous Damage and Development of Squamous Cell Carcinomas1
2004
Transgenic mice overexpressing protein kinase C epsilon in their epidermis exhibit reduced papilloma burden but enhanced carcinoma formation after tumor promotion.
2000
Protein kinase C-epsilon transgenic mice: a unique model for metastatic squamous cell carcinoma.
2001